News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,333 Results
Type
Article (39752)
Company Profile (247)
Press Release (659334)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204191)
Career Advice (2007)
Deals (35421)
Drug Delivery (95)
Drug Development (81057)
Employer Resources (172)
FDA (16192)
Job Trends (14862)
News (345253)
Policy (32553)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49445)
ALS (88)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (126)
Approvals (16194)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11639)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2269)
Cardiovascular disease (175)
Career advice (1676)
Career pathing (30)
CAR-T (152)
Cell therapy (426)
Cervical cancer (19)
Clinical research (66015)
Collaboration (836)
Company closure (1)
Compensation (548)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (243)
Cystic fibrosis (100)
Data (2224)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (272)
Diagnostics (6371)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86689)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112503)
Executive appointments (730)
FDA (17473)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (751)
Gene editing (105)
Generative AI (19)
Gene therapy (304)
GLP-1 (711)
Government (4418)
Grass and pollen (4)
Guidances (79)
Healthcare (18819)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16511)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7916)
Liver cancer (76)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (68)
Medical device (13404)
Medtech (13409)
Mergers & acquisitions (19462)
Metabolic disorders (690)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1915)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (366)
Opinion (204)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (148)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (46)
People (57323)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20570)
Phase II (29069)
Phase III (21653)
Pipeline (1225)
Policy (140)
Postmarket research (2566)
Preclinical (8747)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5908)
Recruiting (65)
Regulatory (22298)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (29)
Vaccines (690)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (173)
Last 7 days (844)
Last 30 days (2662)
Last 365 days (32797)
2025 (10935)
2024 (35224)
2023 (40087)
2022 (51177)
2021 (55716)
2020 (54099)
2019 (46543)
2018 (35026)
2017 (32129)
2016 (31495)
2015 (37569)
2014 (31334)
2013 (26375)
2012 (28590)
2011 (29279)
2010 (27377)
Location
Africa (719)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37879)
Australia (6190)
California (6183)
Canada (2030)
China (526)
Colorado (266)
Connecticut (275)
Delaware (150)
Europe (81340)
Florida (916)
Georgia (207)
Idaho (57)
Illinois (539)
India (25)
Indiana (312)
Iowa (11)
Japan (165)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4603)
Michigan (220)
Minnesota (396)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1740)
New Mexico (28)
New York (1760)
North Carolina (970)
North Dakota (8)
Northern California (2705)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1385)
Puerto Rico (12)
Rhode Island (33)
South America (1097)
South Carolina (23)
South Dakota (1)
Southern California (2327)
Tennessee (102)
Texas (916)
United States (23285)
Utah (183)
Virginia (146)
Washington D.C. (63)
Washington State (553)
West Virginia (3)
Wisconsin (54)
699,333 Results for "transcat inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Transcat Inc. Announces Executive Leadership Changes - April 09, 2024
Transcat Inc. announced that Mark Doheny will step down as Chief Operating Officer of Transcat effective immediately.
April 9, 2024
·
4 min read
Press Releases
Transcat Reports Second Quarter Results with Growth in Revenue and Gross Profit
October 29, 2024
·
18 min read
Deals
Transcat accelerates the growth of its high margin rental business with the acquisition of Axiom Test Equipment, Inc.
Transcat, Inc. announced that it has acquired all of the capital stock of privately-held Axiom Test Equipment, Inc., effective August 8, 2023.
August 8, 2023
·
6 min read
Deals
Transcat Extends Its Professional Services Business With Acquisition of SteriQual, Inc.
Transcat, Inc., a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held SteriQual, Inc., effective July 12, 2023.
July 12, 2023
·
5 min read
Business
Transcat Announces First Quarter Fiscal Year 2024 Conference Call and Webcast
Transcat, Inc. announced that it will release its first quarter fiscal year 2024 results after the close of financial markets on Monday, July 31, 2023.
July 17, 2023
·
2 min read
Deals
Transcat Strengthens Midwest Presence with Acquisition of St. Louis based TIC-MS, Inc.
Transcat, Inc., a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held TIC-MS, Inc., effective March 27, 2023.
March 27, 2023
·
4 min read
Pharm Country
Transcat, Inc. to Participate in the 35th Annual Roth Conference in Dana Point, California
Transcat, Inc. announce that Lee Rudow, President and Chief Executive Officer, and Tom Barbato, Chief Financial Officer, will be available for investor meetings at the Roth Conference on Monday, March 13 and Tuesday, March 14, 2023 at the Ritz Carlton, Laguna Niguel in Dana Point, California.
February 28, 2023
·
2 min read
Business
Transcat Announces Second Quarter Fiscal Year 2023 Conference Call and Webcast
Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2023 results after the close of financial markets on Monday, October 31, 2022.
October 18, 2022
·
2 min read
Pharm Country
Transcat, Inc. to Present at Sidoti Small Cap Virtual Investor Conference
Transcat, Inc. announced that Lee D. Rudow, President and Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Sidoti Small Cap Virtual Investor Conference on Wednesday, March 23 and Thursday, March 24, 2022.
March 14, 2022
·
2 min read
Deals
Transcat Establishes Calibration Presence in Ireland with Acquisition of Complete Calibrations and acquires Cleveland-based e2b Calibration
Transcat, Inc. announced that it has purchased all of the capital stock of privately-held Galium Limited, effective September 28, 2022.
September 28, 2022
·
6 min read
1 of 69,934
Next